Marius Gilbert

Monitoring regulated quarantine plant pathogens and, when relevant, their vectors is compulsory in the European Union. Local Monochamus species (Coleoptera, Cerambycidae) vector the pine wood nematode, Bursaphelenchus xylophilus , a non-native pest already established in most of Portugal. Only 29 M. galloprovincialis individuals were trapped in Belgium in ten years (2013–2022), despite a dense coverage of pheromone-baited traps, suggesting absence or a very rare local occurrence in the country. In the northern neighbouring countries, only one single established population is known in The Netherlands and one in Denmark. A species distribution model based on pheromone-trap catches (negative and positive) of M. galloprovincialis from 4,914 traps in 29 European countries between 2008 and 2019 was developed, using the overall climate conditions and the distribution of seven pine tree species as explanatory variables. The effect of spatial scale was tested with a multi-scale approach. With a 225*225 km spatial grain, the major explanatory variables were the mean diurnal temperature range and, to a lesser extent, the presence of Pinus spp. The model predicted a low probability of presence in Belgium, the Netherlands, Great Britain and north-western Germany compared to southern Europe. Genotyping allowed to conclude that at least some of the beetles caught in Belgium originated from foreign locations. All catches were located close to entry points, suggesting introduction with imported material. The small size of most of the Belgian pine stands may also explain the absence or apparently transient status, or rareness of Monochamus spp. This study thus suggests that surveys in Belgium should privilege entry points rather than local forest stands.

BACKGROUND: Advanced outbreak analytics were instrumental in informing governmental decision-making during the COVID-19 pandemic. However, systematic evaluations of how modelling practices, data use and science–policy interactions evolved during this and previous emergencies remain scarce. AIM: This study assessed the evolution of modelling practices, data usage, gaps, and engagement between modellers and decision-makers to inform future global epidemic intelligence. METHODS: We conducted a two-stage semiquantitative survey among modellers in a large European epidemic intelligence consortium. Responses were analysed descriptively across early, mid- and late-pandemic phases. We used policy citations in Overton to assess policy impact. RESULTS: Our sample included 66 modelling contributions from 11 institutions in four European countries. COVID-19 modelling initially prioritised understanding epidemic dynamics; evaluating non-pharmaceutical interventions and vaccination impacts later became equally important. Traditional surveillance data (e.g. case line lists) were widely available in near-real time. Conversely, real-time non-traditional data (notably social contact and behavioural surveys) and serological data were frequently reported as lacking. Gaps included poor stratification and incomplete geographical coverage. Frequent bidirectional engagement with decision-makers shaped modelling scope and recommendations. However, fewer than half of the studies shared open-access code. CONCLUSIONS: We highlight the evolving use and needs of modelling during public health crises. Persistent gaps in the availability of non-traditional data underscore the need to rethink sustainable data collection and sharing practices, including from for-profit providers. Future preparedness should focus on strengthening collaborative platforms, research consortia and modelling networks to foster data and code sharing and effective collaboration between academia, decision-makers and data providers.

The fast rate of evolution in RNA viruses implies that their evolutionary and ecological processes occur on the same time scale. Genome sequences of these pathogens can therefore contain information about the processes that govern their transmission and dispersal. In particular, landscape phylogeographic approaches use phylogeographic reconstructions to investigate the impact of environmental factors and variables on the spatial spread of viruses. Here, we extend and improve existing approaches and develop three novel landscape phylogeographic methods that can test the impact of continuous environmental factors on the diffusion velocity of viral lineages. In order to evaluate the different methods, we also implemented two simulation frameworks to test and compare their statistical performance. The results enable us to formulate clear guidelines for the use of three complementary landscape phylogeographic approaches that have sufficient statistical power and low rates of false positives. Our open-source methods are available to the scientific community and can be used to investigate the drivers of viral spread, with potential benefits for understanding virus epidemiology and designing tailored intervention strategies.

Introduction: Advanced outbreak analytics played a key role in governmental decision-making as the COVID-19 pandemic challenged health systems globally. This study assessed the evolution of European modelling practices, data usage, gaps, and interactions between modellers and decision-makers to inform future investments in epidemic-intelligence globally. Methods: We conducted a two-stage semi-quantitative survey among modellers in a large European epidemic-intelligence consortium. Responses were analysed descriptively across early, mid-, and late-pandemic phases. Policy citations in Overton were used to assess the policy impact of modelling. Findings: Our sample included 66 modelling contributions from 11 institutions in four European countries. COVID-19 modeling initially prioritised understanding epidemic dynamics, while evaluating non-pharmaceutical interventions and vaccination impacts became equally important in later phases. ‘Traditional’ surveillance data (e.g. case linelists) were widely used in near-real time, while real-time non-traditional data (notably social contact and behavioural surveys), and serological data were frequently reported as lacking. Data limitations included insufficient stratification and geographical coverage. Interactions with decision-makers were commonplace and informed modelling scope and, vice versa, supported recommendations. Conversely, fewer than half of the studies shared open-access code. Interpretation: We highlight the evolving use and needs of modelling during public health crises. The reported missing of non-traditional surveillance data, even two years into the pandemic, underscores the need to rethink sustainable data collection and sharing practices, including from for-profit providers. Future preparedness should focus on strengthening collaborative platforms, research consortia and modelling networks to foster data and code sharing and effective collaboration between academia, decision-makers, and data providers.

By 2050, half of the net increase in the world’s population is expected to reside in sub-Saharan Africa (SSA), driving high urbanization rates and drastic land cover changes. However, the data-scarce environment of SSA limits our understanding of the urban dynamics in the region. In this context, Earth Observation (EO) is an opportunity to gather accurate and up-to-date spatial information on urban extents. During the last decade, the adoption of open-access policies by major EO programs (CBERS, Landsat, Sentinel) has allowed the production of several global high resolution (10–30 m) maps of human settlements. However, mapping accuracies in SSA are usually lower, limited by the lack of reference datasets to support the training and the validation of the classification models. Here we propose a mapping approach based on multi-sensor satellite imagery (Landsat, Sentinel-1, Envisat, ERS) and volunteered geographic information (OpenStreetMap) to solve the challenges of urban remote sensing in SSA. The proposed mapping approach is assessed in 17 case studies for an average F1-score of 0.93, and applied in 45 urban areas of SSA to produce a dataset of urban expansion from 1995 to 2015. Across the case studies, built-up areas averaged a compound annual growth rate of 5.5% between 1995 and 2015. The comparison with local population dynamics reveals the heterogeneity of urban dynamics in SSA. Overall, population densities in built-up areas are decreasing. However, the impact of population growth on urban expansion differs depending on the size of the urban area and its income class.

Using publicly available data on the number of new hospitalisations we use a newly developed phase portrait to monitor the epidemic allowing for assessing whether or not intervention measures are needed to keep hospital capacity under control. Using this phase portrait, we show that intervention measures were effective in mitigating a Summer resurgence but that too little too late was done to prevent a large autumn wave in Belgium.

Demand for animal protein is rising globally and has been facilitated by the expansion of intensive farming. However, intensive animal production relies on the regular use of antimicrobials to maintain health and productivity on farms. The routine use of antimicrobials fuels the development of antimicrobial resistance, a growing threat for the health of humans and animals. Monitoring global trends in antimicrobial use is essential to track progress associated with antimicrobial stewardship efforts across regions. We collected antimicrobial sales data for chicken, cattle, and pig systems in 41 countries in 2017 and projected global antimicrobial consumption from 2017 to 2030. We used multivariate regression models and estimated global antimicrobial sales in 2017 at 93,309 tonnes (95% CI: 64,443, 149,886). Globally, sales are expected to rise by 11.5% in 2030 to 104,079 tonnes (95% CI: 69,062, 172,711). All continents are expected to increase their antimicrobial use. Our results show lower global antimicrobial sales in 2030 compared to previous estimates, owing to recent reports of decrease in antimicrobial use, in particular in China, the world’s largest consumer. Countries exporting a large proportion of their production are more likely to report their antimicrobial sales data than countries with small export markets.